iReadMore ne fonctionne plus
Avez-vous des problèmes aussi? Sélectionnez les erreur que vous rencontrez ci-dessous et aidez à fournir des commentaires à l'application.
Vous avez un problème avec iReadMore? Signaler un problème
Problèmes courants de l'application iReadMore et comment les résoudre. Guide de dépannage
Guide complet pour dépanner l'application iReadMore sur les appareils iOS et Android. Résolvez tous les problèmes, erreurs, problèmes de connexion, problèmes d'installation et plantages de l'application iReadMore.
Table des Contenu:
Nous comprenons que certains problèmes sont tout simplement trop difficiles à résoudre grâce à des didacticiels en ligne et à l'auto-assistance. C'est pourquoi nous avons facilité la prise de contact avec l'équipe d'assistance de Alex Leff, les développeurs de iReadMore.
E-mail vérifié
Courriel de contact: [email protected]
It was shown to improve reading ability in people with pure alexia (Woodhead et al. , 2013) and central alexia (Woodhead et al. - In the clinical trial of cette application for central alexia (the most common form of acquired reading disorder), the average improvement in reading accuracy was 8. 7% for trained words. Integrated Feedback - Complete reading tests and see your own progress. - cette application therapy has been tested in two clinical trials. cette application is a new reading therapy for improving single word reading ability. Three months after finishing the therapy, users still had significantly better reading ability than before they started. - Anonymised results from the app will be collected to test how effective the app is and to improve our understanding of reading rehabilitation. Adaptive Algorithm - cette application adapts to your abilities, keeping the therapy relevant and challenging. Self-led Therapy - cette application allows you to be in control of your own therapy with unlimited access. If you have any other questions, please email us at cette application@ucl. ac. cette application is a Class I CE marked medical device. It is for people with an acquired reading disorder (alexia) or aphasia due to a stroke, brain injury or dementia. Science-Driven and Clinically-Proven Results - All of our therapies are developed through years of dedicated research at University College London by a team of scientists and clinicians.
